Primary Human Cells
Primary Human Cells - Related Videos
10:02
piggyBac Transposon System Modification of Primary Human T Cells
0 Views •
Cited by 16 •
2012
We describe a method to genetically modify primary human T cells with a transgene using the non-viral piggyBac transposon system. T cells modified to using the piggyBac transposon system exhibit stable transgene expression.
14:32
Primary Human Bronchial Epithelial Cells Grown from Explants
0 Views •
Cited by 19 •
2010
Here we describe a detailed method for growing primary human bronchial epithelial cells from explants of human bronchial airway tissue including differentiated growth on an air-liquid interface. This method provides an abundant source of primary cells for investigating the role of the airway epithelium in human lung health and disease.
10:15
Small RNA Transfection in Primary Human Th17 Cells by Next Generation Electroporation
0 Views •
Cited by 5 •
2017
Next generation electroporation is an efficient method for transfecting human Th17 cells with small RNAs to alter gene expression and cell behavior.
14:23
Generation of Induced Regulatory T Cells from Primary Human Naïve and Memory T Cells
0 Views •
Cited by 29 •
2012
We describe a method for generating regulatory, memory and naïve T cells from a single human blood donor. Polarized Tregs can be then compared to other subsets in a variety of genetic and functional applications with genetic homogeneity, including a suppression assay also detailed here.
09:12
Optimal Lentivirus Production and Cell Culture Conditions Necessary to Successfully Transduce Primary Human Bronchial Epithelial Cells
0 Views •
Cited by 13 •
2016
Primary human bronchial epithelial cells are difficult to transduce. This protocol describes the production of lentiviruses and their concentration as well as the optimal culture conditions necessary to achieve highly efficient transductions in these cells throughout differentiation to a pseudostratified epithelium.
FAQs
Two constraints shape experimental design: limited lifespan and donor variability. Because primary human cells do not remain viable indefinitely, studies may require carefully controlled culture periods and consistent handling. Donors can also differ in their baseline characteristics and responses, so findings should be interpreted with donor identity and between-donor variation in mind rather than treated as universally identical.
Cell behavior depends on more than nutrient availability. Adhesion cues help cells attach and interact with their culture environment, while growth factors support maintenance or activity. Controlled physical signals add another layer of regulation. In bioengineered systems, adjusting these inputs allows researchers to examine how the surrounding environment influences cell behavior while retaining donor-specific characteristics.
Compared with immortalized cell lines, primary human cells often provide more physiologically relevant evidence for evaluating normal function, disease-related behavior, and therapeutic responses. Their finite lifespan and donor-to-donor variation can complicate experiments, however. This tradeoff matters when selecting a model for bioengineering studies that must balance biological relevance with experimental consistency.
A typical workflow begins by dissociating tissue into a usable cell preparation, followed by enrichment of the desired population. The selected cells are then maintained under controlled culture conditions that provide appropriate nutrients, adhesion cues, growth factors, and physical signals. This sequence helps connect cell handling with the engineered environment being tested.
Primary human cells support several bioengineering applications, including tissue engineering, organ-on-chip systems, biomaterial testing, and regenerative medicine. In each setting, they can help researchers assess how an engineered environment affects cell behavior. This makes them useful for examining whether a material, device, or engineered tissue context produces responses that remain relevant to human biology.
Donor-specific characteristics are not merely background details; they can shape how cells behave in culture and respond to engineered conditions. Preserving those characteristics can make results more biologically informative, while donor variability can complicate comparisons across experiments. This context is especially important when assessing biomaterials, tissue-engineered environments, or therapeutic effects.